Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T15:24:16.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page adds an Amyloidosis topic and a Genetic and Rare Diseases Information Center resource, along with a new citation for a 2026 JAMA Cardiol article. A previously listed JAMA Cardiol article reference was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:57:12.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-07T05:17:54.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Show glossary option added; Brno-střed, Czechia added as a location. QC-related text updated (Last Update Submitted that Met QC Criteria) and the revision shows v3.4.0, with capitalization changes for No FEAR Act Data.
    Difference
    0.1%
    Check dated 2026-01-23T23:55:10.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added a citation for a plain-language review of ATTRibute-CM by Gillmore et al. (Future Cardiol. 2025) to Publications. Removed the older online-ahead-of-print citation and updated the entry to Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-17T00:27:07.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Locations section expanded with numerous new sites across the US, Canada, Europe, and other regions, and some sites were removed. This changes the set of enrollment locations for the study.
    Difference
    2%
    Check dated 2025-12-19T05:38:48.000Z thumbnail image

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.